TCL Archive In Brief: New Cancer control Program On Schedule; NCI Expects 10-15CCRU, 30-40 CCSP Applications July 2, 1982
TCL Archive NCI Accused Of forsaking Its Mission In House Hearing On Screening Statement March 18, 1994
TCL Archive Enzalutamide Reduced Risk of Progression By 81 Percent in Metastatic Prostate Cancer June 27, 2014
TCL Archive In Brief: Thomas Jordan Promoted At Bristol-Myers, Markison To Succeed Him In Oncology Div. February 28, 1992
